D&A

Name: ANI Pharmaceuticals D&A by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

ANI Pharmaceuticals·Business Segments·2 segments·Rolls up to D&A

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Generics and Other	$0	$0	$0	$0	$0
Rare Disease and Brands	$0	$0	$0	$0	$0
Total	$22.89M	$23.28M	$22.63M	$22.61M	$20.92M

Generics and OtherView metric

Rare Disease and BrandsView metric